CisThera

Launched: 

2011

Sector: 

CisThera mission is to develop innovative therapeutics to treat cancer, autoimmune diseases, as well as chronic kidney and liver diseases. CisThera is taking a novel approach to identify drugs with greater efficacy that broadly inhibit validated contributors to disease pathogenesis.

Team: 

Don Staunton, President and Chief Scientific Officer
John Harlan, Co-Founder, Associate Medical Director at Harborview Medical Center